MUC5B基因多态性rs35705950-T与COVID-19住院风险的关系
基于Million Veteran Program(MVP)参与者的基因分型与电子健康记录,评估MUC5B rs35705950-T与COVID-19感染及严重结局的关联,并与COVID-19 Host Genetics Initiative(HGI)进行联合荟萃分析。该等位基因与跨 ancestry 荟萃分析中较少的COVID-19住院相关,但未与重症或死亡风险降低相关。
要点
- rs35705950-T与MVP中跨 ancestry 荟萃分析的COVID-19住院减少相关(OR=0.89)。
- 该等位基因未与重症结局或死亡风险降低相关。
- 在欧洲 ancestry 的MVP个体中,rs35705950-T与较少的COVID-19后肺炎事件相关。
核心结论
- MUC5B变异rs35705950-T可能对COVID-19住院具有保护作用。
研究设计与样本
- 在MVP参与者中直接对MUC5B rs35705950-T等位基因进行基因分型,从电子健康记录提取临床事件与合并症。
- 在各 ancestry 组内分析COVID-19发病率或严重程度与rs35705950-T的关联,随后进行跨 ancestry 荟萃分析。
- 使用COVID-19 Host Genetics Initiative(HGI)的汇总统计进行重复与联合荟萃分析。
- 在MVP受试者中进行调整额外协变量的敏感性分析及与COVID-19后肺炎的关联分析。
主要发现
- MVP跨 ancestry 荟萃分析中,rs35705950-T与较少的COVID-19住院相关(Ncases=4,325;Ncontrols=507,640;OR=0.89 [0.82-0.97];P=6.86×10-3)。
- 与HGI联合荟萃分析中,rs35705950-T与较少的COVID-19住院相关(Ncases=13,320;Ncontrols=1,508,841;OR=0.90 [0.86-0.95];P=8.99×10-5)。
- MVP跨 ancestry 荟萃分析中,rs35705950-T与COVID-19阳性减少无显著关联(Ncases=19,168/Ncontrols=492,854;OR=0.98 [0.95-1.01];P=0.06)。
- 与HGI联合荟萃分析中,rs35705950-T与COVID-19阳性关联名义显著(Ncases=44,820;Ncontrols=1,775,827;OR=0.97 [0.95-1.00];P=0.03)。
- 在MVP欧洲 ancestry 个体中,rs35705950-T与较少的COVID-19后肺炎事件相关(OR=0.82 [0.72-0.93];P=0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: A common MUC5B gene polymorphism, rs35705950-T, is associated with idiopathic pulmonary fibrosis (IPF), but its role in severe acute respiratory syndrome coronavirus 2 infection and disease severity is unclear. Objectives: To assess whether rs35705950-T confers differential risk for clinical outcomes associated with coronavirus disease (COVID-19) infection among participants in the Million Veteran Program (MVP). Methods: The MUC5B rs35705950-T allele was directly genotyped among MVP participants; clinical events and comorbidities were extracted from the electronic health records. Associations between the incidence or severity of COVID-19 and rs35705950-T were analyzed within each ancestry group in the MVP followed by transancestry meta-analysis. Replication and joint meta-analysis were conducted using summary statistics from the COVID-19 Host Genetics Initiative (HGI). Sensitivity analyses with adjustment for additional covariates (body mass index, Charlson comorbidity index, smoking, asbestosis, rheumatoid arthritis with interstitial lung disease, and IPF) and associations with post-COVID-19 pneumonia were performed in MVP subjects. Measurements and Main Results: The rs35705950-T allele was associated with fewer COVID-19 hospitalizations in transancestry meta-analyses within the MVP (Ncases = 4,325; Ncontrols = 507,640; OR = 0.89 [0.82-0.97]; P = 6.86 × 10-3) and joint meta-analyses with the HGI (Ncases = 13,320; Ncontrols = 1,508,841; OR, 0.90 [0.86-0.95]; P = 8.99 × 10-5). The rs35705950-T allele was not associated with reduced COVID-19 positivity in transancestry meta-analysis within the MVP (Ncases = 19,168/Ncontrols = 492,854; OR, 0.98 [0.95-1.01]; P = 0.06) but was nominally significant (P < 0.05) in the joint meta-analysis with the HGI (Ncases = 44,820; Ncontrols = 1,775,827; OR, 0.97 [0.95-1.00]; P = 0.03). Associations were not observed with severe outcomes or mortality. Among individuals of European ancestry in the MVP, rs35705950-T was associated with fewer post-COVID-19 pneumonia events (OR, 0.82 [0.72-0.93]; P = 0.001). Conclusions: The MUC5B variant rs35705950-T may confer protection in COVID-19 hospitalizations.
引用
- Verma A, Minnier J, Wan ES, et al. A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality. Am J Respir Crit Care Med. 2022. PMID: 35771531. doi:10.1164/rccm.202109-2166OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。